Eli Lilly said it is lowering the cash prices of single-dose vials of its blockbuster weight loss drug Zepbound on its direct-to-consumer platform, LillyDirect. Starting Dec. 1, cash-paying patients ...

Amid rising demand of weight loss therapies, Eli Lilly on Monday said that it was cutting the price of its popular obesity drug Zepbound, as it moves forward to make the medicine more accessible in ...

Mounjaro and Zepbound are two brand-name glucagon-like peptide-1 (GLP-1) medications manufactured by Eli Lilly. Although they ...

Eli Lilly released a new form of its weight loss drug Zepbound for roughly half its usual monthly list price to increase access for patients without insurance coverage for the highly popular injection ...

Eli Lilly on Monday, Dec. 1 slashed prices of its blockbuster weight loss drug Zepbound for consumers who buy the prescription medication directly from the drugmaker. Lilly's price cuts ranged from ...

Eli Lilly and Co. this month rolled out plans to offer coverage of its popular obesity medications such as Zepbound through direct-to-employer arrangements set to begin in early 2026. The Indianapolis ...

Eli Lilly announced on "Good Morning America" Monday that its GLP-1 weight-loss drug Zepbound will now be available in a new multi-dose KwikPen, giving patients a simpler way to receive a full month ...

Eli Lilly and Co. reported fourth-quarter results Wednesday that topped Wall Street expectations, with revenue of $19.3 billion — up 43% from the same quarter a year ago, driven by growth in sales of ...

Discover how Eli Lilly is increasing medical weight loss access in Indiana through Zepbound vials. Learn how this Indy innovation supports long-term health. By combining lower pricing, ...

GoodRx Holdings will offer employers access to Eli Lilly's Zepbound through a new program designed to help companies manage the cost of weight-loss drugs. The prescription-drug provider said Friday ...